Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (151-160 of 308) with videos related to

Pageof 31
Sort By:
Annals of the Rheumatic Diseases|June 9, 2022
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic diseaseEdgar Wiebe, Dörte Huscher, Désireé Schaumburg, et al.
The Journal of Rheumatology|May 3, 2015
Consensus on the Need for a Hierarchical List of Patient-reported Pain Outcomes for Metaanalyses of Knee Osteoarthritis Trials: An OMERACT ObjectiveRobin Christensen, Lara J Maxwell, Peter Jüni, et al.
The Journal of Rheumatology|August 3, 2011
Domains selection for patient-reported outcomes: current activities and options for future methodsPeter S Tugwell, Ingemar F Petersson, Maarten Boers, et al.
The Journal of Rheumatology|October 3, 2014
Detection of subclinical synovitis with macrophage targeting and positron emission tomography in patients with rheumatoid arthritis without clinical arthritisYoony Y J Gent, Nazanin Ahmadi, Alexandre E Voskuyl, et al.
Arthritis Care & Research|February 25, 2015
Alternative Ways to Quantify Sustained Remission: Applying the Continuity Rewarded Score and Patient Vector GraphMaud S Jurgens, Johannes W G Jacobs, Maarten Boers, et al.
The Journal of Rheumatology|November 5, 2002
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequenceKarin Bruynesteyn, Désirée Van Der Heijde, Maarten Boers, et al.
Arthritis and Rheumatism|April 16, 2002
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable differenceKarin Bruynesteyn, Désirée van der Heijde, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Arthritis Care & Research|September 29, 2019
First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients With Rheumatoid ArthritisMartine H P Crins, Caroline B Terwee, Rene Westhovens, et al.
The Journal of Rheumatology|July 5, 2011
Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agendaHaner Direskeneli, Sibel Z Aydin, Tanaz A Kermani, et al.
Pageof 31

Showing results (151-160 of 308) with videos related to

Sort By:
Pageof 31
Annals of the Rheumatic Diseases|June 9, 2022
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic diseaseEdgar Wiebe, Dörte Huscher, Désireé Schaumburg, et al.
The Journal of Rheumatology|May 3, 2015
Consensus on the Need for a Hierarchical List of Patient-reported Pain Outcomes for Metaanalyses of Knee Osteoarthritis Trials: An OMERACT ObjectiveRobin Christensen, Lara J Maxwell, Peter Jüni, et al.
The Journal of Rheumatology|August 3, 2011
Domains selection for patient-reported outcomes: current activities and options for future methodsPeter S Tugwell, Ingemar F Petersson, Maarten Boers, et al.
The Journal of Rheumatology|October 3, 2014
Detection of subclinical synovitis with macrophage targeting and positron emission tomography in patients with rheumatoid arthritis without clinical arthritisYoony Y J Gent, Nazanin Ahmadi, Alexandre E Voskuyl, et al.
Arthritis Care & Research|February 25, 2015
Alternative Ways to Quantify Sustained Remission: Applying the Continuity Rewarded Score and Patient Vector GraphMaud S Jurgens, Johannes W G Jacobs, Maarten Boers, et al.
The Journal of Rheumatology|November 5, 2002
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequenceKarin Bruynesteyn, Désirée Van Der Heijde, Maarten Boers, et al.
Arthritis and Rheumatism|April 16, 2002
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable differenceKarin Bruynesteyn, Désirée van der Heijde, Maarten Boers, et al.
Seminars in Arthritis and Rheumatism|July 27, 2023
Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing studyTeresa A Simon, Samy Suissa, Maarten Boers, et al.
Arthritis Care & Research|September 29, 2019
First Validation of the Full PROMIS Pain Interference and Pain Behavior Item Banks in Patients With Rheumatoid ArthritisMartine H P Crins, Caroline B Terwee, Rene Westhovens, et al.
The Journal of Rheumatology|July 5, 2011
Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agendaHaner Direskeneli, Sibel Z Aydin, Tanaz A Kermani, et al.
Pageof 31